DNA Funded vs Earn2Trade (2026) — Which Is Better?

## Overview

DNA Funded and Earn2Trade represent two fundamentally different philosophies in the prop trading space. DNA Funded is a broker-backed challenge platform (3.9/5 rating) offering rapid entry into multi-asset CFD trading through ASIC-regulated infrastructure. Earn2Trade is an education-first futures prop firm (4.0/5 rating) built around structured learning programs and progressive account scaling. DNA Funded targets traders seeking immediate funding with minimal evaluation friction; Earn2Trade targets traders willing to invest in education before scaling to larger accounts.

## Pricing Comparison

DNA Funded costs $49 per month with challenge fees ranging from $49 to $299 depending on account size and challenge type. The Instant Funding option ($299) grants immediate live trading access, while the 2-Phase challenge ($99-$149) requires two evaluation stages. Critically, DNA Funded refunds challenge fees upon first payout, effectively making your entry cost zero if you're profitable within 30 days. There is no annual discount structure, but the fee refund mechanism is genuinely uncommon in the industry.

Earn2Trade charges $99 monthly for access to the Gauntlet Mini program (10-day evaluation) or higher tiers for larger funded accounts. The Trader Career Path starts at $99/mo but requires longer evaluation periods (30 days standard). Unlike DNA Funded, Earn2Trade charges monthly with no fee refund guarantee, meaning failed evaluation attempts cost $99 each. Over six months, a trader cycling through multiple attempts could spend $594 in subscription fees alone. DNA Funded's $49/mo base makes it 51% cheaper for identical timeframes, and the fee refund model dramatically favors profitable traders.

**Pricing winner: DNA Funded** — lower monthly cost plus fee-back-on-profit makes it cheaper upfront and cost-neutral after your first win.

## Key Features Head-to-Head

**Trading Instruments:** DNA Funded offers 800+ CFDs (forex, indices, commodities, stocks, limited crypto) via TradeLocker. Earn2Trade is futures-only—ES, NQ, CL, GC, ZB, and a handful of others. If you trade micro-cap stocks, spot crypto, or forex, DNA Funded is your only option. If you're a futures-focused scalper or trend trader, Earn2Trade covers the instruments you need, but DNA Funded gives you optionality.

**Profit Split:** DNA Funded offers 80% to traders; Earn2Trade offers 80/20 (80% to trader, 20% to the firm). These are identical. However, Topstep offers 90/10 and Apex offers 100% on first $25K, so neither platform leads here. DNA Funded's split is competitive among newer platforms; Earn2Trade's is standard but not best-in-class.

**Account Scaling:** DNA Funded's challenges remain static—you pass the evaluation, you get funded at that level. Earn2Trade's Trader Career Path is built on progression: you start at $25K, pass evaluations, and scale to $100K, then $250K, then $400K. If you're a newer trader wanting to grow into larger positions gradually, Earn2Trade's structure forces accountability and risk management. DNA Funded requires you to request higher challenge sizes separately.

**Evaluation Speed:** Earn2Trade's Gauntlet Mini takes 10 days minimum (shortest in the industry). DNA Funded's Instant Funding takes zero days—you're live immediately after deposit. DNA Funded's 1-Phase and 2-Phase have no stated time limit, though 2-Phase typically takes 30-60 days total. For traders who need capital access this week, DNA Funded wins decisively.

**Education:** Earn2Trade bundles structured learning, live boot camps, and mentorship into its Trader Career Path. DNA Funded does not advertise structured education—it's a challenge platform first. If you need hand-holding and curriculum, Earn2Trade delivers it. If you're self-directed, DNA Funded removes that overhead cost.

**Regulatory Backing:** DNA Funded is backed by DNA Markets, an ASIC-regulated Australian broker. This is exceptionally rare among prop firms and reduces counterparty risk materially. Earn2Trade operates through Helios Trading Partners as its liquidity provider—reputable, but not the same regulatory pedigree. This favors DNA Funded for risk-averse traders.

## Who Should Choose DNA Funded

- **Multi-asset traders** who need access to forex, stocks, indices, and commodities alongside CFDs. If your strategy diversifies across asset classes, DNA Funded's 800+ instruments give you coverage Earn2Trade cannot. - **Traders seeking immediate capital** with minimal evaluation. The Instant Funding option ($299 one-time) gets you live within hours. If you have $1000+ in your account and proven edge, this is faster than any competitor. - **Cost-conscious traders** evaluating multiple prop firms. At $49/mo with challenge fee refunds, DNA Funded's break-even point on fees is a single profitable month—much lower friction than Earn2Trade's $99/mo burn. - **Traders skeptical of prop firm regulation.** The ASIC backing and TradeLocker integration provide institutional legitimacy. If you've been burned by offshore prop firms, DNA Funded's transparency here is worth the premium.

## Who Should Choose Earn2Trade

- **Futures-exclusive traders** (day traders on ES, NQ, CL, or others). Earn2Trade's depth in micro e-mini contracts and 10-day evaluation cycle is optimized for this workflow. DNA Funded doesn't support futures at all. - **Traders willing to invest in education** as part of their scaling journey. The Trader Career Path, live boot camps, and mentorship add $0 to the monthly fee but provide significant value for someone still building confidence. This is worth the $99/mo if you're pre-profitable. - **Traders seeking progressive account scaling** with built-in checkpoints. If you want accountability and forced risk discipline as you grow from $25K to $100K to $250K, Earn2Trade's structure enforces it. DNA Funded doesn't provide this scaffolding. - **Traders prioritizing track record over novelty.** Earn2Trade has years of Trustpilot reviews and community validation. DNA Funded launched in 2024. If you want to trade through an established firm, Earn2Trade's credibility gap matters.

## The Verdict

DNA Funded wins on cost, speed, and asset diversity—choose it if you're self-directed, multi-asset, and want to fund within 48 hours. Earn2Trade wins on education, futures-specific optimization, and structured accountability—choose it if you're building an edge in the e-mini space and value mentorship alongside funding. DNA Funded is the faster, cheaper entry point ($49/mo, Instant Funding in hours); Earn2Trade is the slower, more intentional builder's platform ($99/mo, 10-day gauntlet, progressive scaling). If you've already passed one prop firm evaluation, DNA Funded is the obvious choice. If you're evaluating prop firms for the first time and can afford $99/mo, Earn2Trade's education subsidy justifies the cost difference.